Home Cart 0 Sign in  
X

[ CAS No. 23031-78-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 23031-78-9
Chemical Structure| 23031-78-9
Chemical Structure| 23031-78-9
Structure of 23031-78-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 23031-78-9 ]

Related Doc. of [ 23031-78-9 ]

Alternatived Products of [ 23031-78-9 ]

Product Details of [ 23031-78-9 ]

CAS No. :23031-78-9 MDL No. :MFCD00726295
Formula : C7H6N2S Boiling Point : -
Linear Structure Formula :- InChI Key :WIJQCPIRWXSWQG-UHFFFAOYSA-N
M.W : 150.20 Pubchem ID :89966
Synonyms :

Calculated chemistry of [ 23031-78-9 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 44.02
TPSA : 67.15 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.8 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.49
Log Po/w (XLOGP3) : 1.99
Log Po/w (WLOGP) : 1.89
Log Po/w (MLOGP) : 1.25
Log Po/w (SILICOS-IT) : 2.47
Consensus Log Po/w : 1.82

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.69
Solubility : 0.306 mg/ml ; 0.00204 mol/l
Class : Soluble
Log S (Ali) : -3.03
Solubility : 0.141 mg/ml ; 0.000941 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.59
Solubility : 0.384 mg/ml ; 0.00256 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.96

Safety of [ 23031-78-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 23031-78-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 23031-78-9 ]
  • Downstream synthetic route of [ 23031-78-9 ]

[ 23031-78-9 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 18637-02-0 ]
  • [ 23031-78-9 ]
Reference: [1] Green Chemistry, 2018, vol. 20, # 4, p. 827 - 831
  • 2
  • [ 7716-66-7 ]
  • [ 23031-78-9 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1988, # 1, p. 326 - 345
  • 3
  • [ 29109-77-1 ]
  • [ 23031-78-9 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1977, p. 20 - 26
  • 4
  • [ 19331-28-3 ]
  • [ 23031-78-9 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1977, p. 20 - 26
  • 5
  • [ 23031-78-9 ]
  • [ 367514-88-3 ]
Reference: [1] Patent: WO2013/14665, 2013, A1, . Location in patent: Page/Page column 21
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 23031-78-9 ]

Lurasidone Intermediates

Chemical Structure| 186204-35-3

[ 186204-35-3 ]

(R,R)-1,2-Bis(Methanesulphonyloxymethyl)cyclohexane

Chemical Structure| 65376-05-8

[ 65376-05-8 ]

(1R,2R)-Cyclohexane-1,2-diyldimethanol

Chemical Structure| 110-17-8

[ 110-17-8 ]

Fumaric acid

Chemical Structure| 87691-87-0

[ 87691-87-0 ]

3-(1-Piperazinyl)-1,2-benzisothiazole

Chemical Structure| 2305-32-0

[ 2305-32-0 ]

trans-Cyclohexane-1,2-dicarboxylic acid

Related Functional Groups of
[ 23031-78-9 ]

Amines

Chemical Structure| 613262-16-1

[ 613262-16-1 ]

5-Bromobenzo[d]isothiazol-3-amine

Similarity: 0.76

Chemical Structure| 53473-85-1

[ 53473-85-1 ]

Benzo[d]isothiazol-5-amine

Similarity: 0.67

Chemical Structure| 5434-06-0

[ 5434-06-0 ]

4-Methanesulfonylbenzamidine hydrochloride

Similarity: 0.54

Chemical Structure| 56891-64-6

[ 56891-64-6 ]

Isothiazolo[5,4-b]pyridin-3-amine

Similarity: 0.53

Chemical Structure| 1823368-22-4

[ 1823368-22-4 ]

5-Bromoisothiazolo[3,4-b]pyridin-3-amine

Similarity: 0.52